Literature DB >> 16857355

Pharmaceutical prerequisites for a multi-target therapy.

U Kroll1, C Cordes.   

Abstract

The quality of a phytomedicine is defined by the quality of the herbal drug, the manufacturing of the drug preparations and the properties of the finished product, taking into account the special requirements of the individual herbal species in accordance with Good Manufacturing Practice (GMP) standards [2003. Medicinal Products for Human and Veterinary Use. Eudralex, vol. 4 (2003/94/EC)]. The quality control of the complete process is based on pharmacognostic methods, characteristic fingerprint chromatograms, defined amounts of marker substances, physicochemical characteristics and microbiological monitoring. For a herbal multi-component preparation used in multi-target therapy, these pharmaceutical prerequisites have to be ensured for all components and for their combination, as is exemplified by Iberogast((R)) (STW 5) a fixed combination of hydroethanolic extracts of bitter candytuft (Iberis amara), angelica root (Angelicae radix), milk thistle fruit (Silybi mariani fructus), celandine herb (Chelidonii herba), caraway fruit (Carvi fructus), liquorice root (Liquiritiae radix), peppermint herb (Menthae piperitae folium), balm leaf (Melissae folium) and chamomile flower (Matricariae flos) using in the therapy of gastrointestinal complaints (Rösch et al., 2006). The prerequisites for the quality of each of its components according to actual standards are at first the cultivation of the plant material according to the Guidelines for Good Agricultural Practice (GAP) conditions of Medicinal and Aromatic Plants [1998. Z. Arzn. Gew. Pfl. 3, 166-178] to yield a defined raw material of high quality. Characteristic compounds of the extracts had to be identified and different analytical methods such as HPLC, with low coefficients of variation had to be developed to analyze each of the standardized ethanolic extracts and the finished product. At the example of the extract of I. amara these necessary investigations are described. The variability of the plant material in its natural habitats, the identification of characteristic compounds and exemplary chromatograms for fingerprint evaluation and quantification are shown. These data are required for characterization of the profile of the active substances in the finished product.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857355     DOI: 10.1016/j.phymed.2006.03.016

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  12 in total

1.  Chamomile: A herbal medicine of the past with bright future.

Authors:  Janmejai K Srivastava; Eswar Shankar; Sanjay Gupta
Journal:  Mol Med Rep       Date:  2010-11-01       Impact factor: 2.952

Review 2.  [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].

Authors:  Hans-Dieter Allescher; Hildebert Wagner
Journal:  Wien Med Wochenschr       Date:  2007

3.  Iberis amara Extract Induces Intracellular Formation of Reactive Oxygen Species and Inhibits Colon Cancer.

Authors:  Christopher Weidner; Morten Rousseau; Annabell Plauth; Sylvia J Wowro; Cornelius Fischer; Heba Abdel-Aziz; Sascha Sauer
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

4.  Pharmacognostical Analysis and Protective Effect of Standardized Extract and Rizonic Acid from Erythrina velutina against 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Aline H Silva; Francisco Noé Fonseca; Antônia T A Pimenta; MaryAnne S Lima; Edilberto Rocha Silveira; Glauce S B Viana; Silvânia M M Vasconcelos; Luzia Kalyne A M Leal
Journal:  Pharmacogn Mag       Date:  2016 Oct-Dec       Impact factor: 1.085

5.  Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells.

Authors:  Mathias Schneider; Thomas Efferth; Heba Abdel-Aziz
Journal:  Front Pharmacol       Date:  2016-10-26       Impact factor: 5.810

Review 6.  Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.

Authors:  Ahmed Madisch; Bettina R Vinson; Heba Abdel-Aziz; Olaf Kelber; Karen Nieber; Karin Kraft; Martin Storr
Journal:  Wien Med Wochenschr       Date:  2017-04-19

7.  Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation.

Authors:  Karl Rüdiger Wiebelitz; André-Michael Beer
Journal:  Int J Gen Med       Date:  2012-10-16

8.  A "novel" protocol for the analysis of hydroxycinnamic acids in leaf tissue of chicory (Cichorium intybus L., Asteraceae).

Authors:  Meriem Bahri; Philippe Hance; Sébastien Grec; Marie-Christine Quillet; Francis Trotin; Jean-Louis Hilbert; Theo Hendriks
Journal:  ScientificWorldJournal       Date:  2012-12-05

9.  Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial.

Authors:  Jonathan Corren; Marc Lemay; Yumei Lin; Lisa Rozga; R Keith Randolph
Journal:  Nutr J       Date:  2008-07-14       Impact factor: 3.271

10.  Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family.

Authors:  Christopher Weidner; Sylvia J Wowro; Morten Rousseau; Anja Freiwald; Vitam Kodelja; Heba Abdel-Aziz; Olaf Kelber; Sascha Sauer
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.